[
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Down, But Amazon Leaps On OpenAI Move; This Stock Soars On Microsoft Deal (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index slips Monday. Amazon stock soars on deal with OpenAI. Kimberly-Clark plunges.",
    "url": "https://finnhub.io/api/news?id=0f5e750015673b217394c44043decb4a288e021cfcf3ff50f0e81f6140117ca7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762195087,
      "headline": "Stock Market Today: Dow Down, But Amazon Leaps On OpenAI Move; This Stock Soars On Microsoft Deal (Live Coverage)",
      "id": 137305820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Stock Market Today: The Dow Jones index slips Monday. Amazon stock soars on deal with OpenAI. Kimberly-Clark plunges.",
      "url": "https://finnhub.io/api/news?id=0f5e750015673b217394c44043decb4a288e021cfcf3ff50f0e81f6140117ca7"
    }
  },
  {
    "ts": null,
    "headline": "Rare Earth Elements Market Global Forecast Report 2025-2030, Company Profiles of Leading Players - Lynas Rare Earths, Aluminum Corp of China, MP Materials, Solvay, Merck",
    "summary": "Executives in the rare earth elements market can leverage opportunities in electrification, defense, and renewable supply chains, address supply chain complexities, and capitalize on advances in separation and recycling technologies. A focus on sustainability, regional shifts, and strategic partnerships is crucial for navigating this evolving landscape. Rare Earth Elements Market Rare Earth Elements Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The \"Rare Earth Elements Market - Global Forecas",
    "url": "https://finnhub.io/api/news?id=e79a89071dd97f8334befccdde920220cc9f67b692a68ec157a0a89872dc35fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762187340,
      "headline": "Rare Earth Elements Market Global Forecast Report 2025-2030, Company Profiles of Leading Players - Lynas Rare Earths, Aluminum Corp of China, MP Materials, Solvay, Merck",
      "id": 137305967,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Executives in the rare earth elements market can leverage opportunities in electrification, defense, and renewable supply chains, address supply chain complexities, and capitalize on advances in separation and recycling technologies. A focus on sustainability, regional shifts, and strategic partnerships is crucial for navigating this evolving landscape. Rare Earth Elements Market Rare Earth Elements Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The \"Rare Earth Elements Market - Global Forecas",
      "url": "https://finnhub.io/api/news?id=e79a89071dd97f8334befccdde920220cc9f67b692a68ec157a0a89872dc35fb"
    }
  },
  {
    "ts": null,
    "headline": "Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corporation on a Historic Investment to Create the Nation’s Largest Workforce Development Center for Advanced Pharmaceutical Manufacturing",
    "summary": "RICHMOND, Va, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), congratulates Governor Glenn Youngkin, the Virginia Innovation Partnership Corporation (VIPC), and several leading Virginia universities on the recent announcement of a $120 million investment from AstraZeneca, Eli Lilly and Company, and Merck to expand Virginia’s life sciences and advanced pharmaceutical manufacturing workforce devel",
    "url": "https://finnhub.io/api/news?id=2cc0e1a0e98754222ac40f68294eda1f4aaf3a2629168dfb7b41948125bf1668",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762184340,
      "headline": "Phlow Corp. Congratulates the Commonwealth of Virginia and the Virginia Innovation Partnership Corporation on a Historic Investment to Create the Nation’s Largest Workforce Development Center for Advanced Pharmaceutical Manufacturing",
      "id": 137302925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RICHMOND, Va, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), congratulates Governor Glenn Youngkin, the Virginia Innovation Partnership Corporation (VIPC), and several leading Virginia universities on the recent announcement of a $120 million investment from AstraZeneca, Eli Lilly and Company, and Merck to expand Virginia’s life sciences and advanced pharmaceutical manufacturing workforce devel",
      "url": "https://finnhub.io/api/news?id=2cc0e1a0e98754222ac40f68294eda1f4aaf3a2629168dfb7b41948125bf1668"
    }
  },
  {
    "ts": null,
    "headline": "ESMO 2025: Sichuan-Kelun moves in breast cancer ADC space",
    "summary": "Sac-TMT will compete with two other TROP-2 targeted ADCs already approved: Gilead’s Trodelvy and AstraZeneca and Daiichi Sankyo’s Datroway.",
    "url": "https://finnhub.io/api/news?id=62c1e8336d95ff990a8fd5cdc71bde6e17f8e0e0a00ae6c6e08b0fecb7748c55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762173341,
      "headline": "ESMO 2025: Sichuan-Kelun moves in breast cancer ADC space",
      "id": 137302321,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Sac-TMT will compete with two other TROP-2 targeted ADCs already approved: Gilead’s Trodelvy and AstraZeneca and Daiichi Sankyo’s Datroway.",
      "url": "https://finnhub.io/api/news?id=62c1e8336d95ff990a8fd5cdc71bde6e17f8e0e0a00ae6c6e08b0fecb7748c55"
    }
  },
  {
    "ts": null,
    "headline": "Are Wall Street Analysts Predicting Merck & Co. Stock Will Climb or Sink?",
    "summary": "Despite Merck & Co.’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=0ee23612e8960f1ed74e26d739f149eeb849f0222ccebc413379ac96191c54c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762171891,
      "headline": "Are Wall Street Analysts Predicting Merck & Co. Stock Will Climb or Sink?",
      "id": 137302969,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Despite Merck & Co.’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=0ee23612e8960f1ed74e26d739f149eeb849f0222ccebc413379ac96191c54c9"
    }
  },
  {
    "ts": null,
    "headline": "Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.",
    "summary": "RAHWAY, N.J., November 03, 2025--Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.",
    "url": "https://finnhub.io/api/news?id=263be0cb74e8913148fe29deb2a716dae1c2b510df38b488fa1a171b153d1bb8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762170300,
      "headline": "Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.",
      "id": 137302322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., November 03, 2025--Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.",
      "url": "https://finnhub.io/api/news?id=263be0cb74e8913148fe29deb2a716dae1c2b510df38b488fa1a171b153d1bb8"
    }
  },
  {
    "ts": null,
    "headline": "ESMO 2025: Bayer and BI neck and neck in first line HER2+ NSCLC",
    "summary": "Bayer and BI have reported broadly similar efficacy outcomes for sevabertinib and Hernexeos.",
    "url": "https://finnhub.io/api/news?id=78ab0bc41aeb6c461f91b19e25a67408dfff9baad5a85eabf0b6cb2606874727",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762169707,
      "headline": "ESMO 2025: Bayer and BI neck and neck in first line HER2+ NSCLC",
      "id": 137302323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Bayer and BI have reported broadly similar efficacy outcomes for sevabertinib and Hernexeos.",
      "url": "https://finnhub.io/api/news?id=78ab0bc41aeb6c461f91b19e25a67408dfff9baad5a85eabf0b6cb2606874727"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. (MRK) Reports Solid Q3 with Strong Drug Sales and Pipeline Progress",
    "summary": "Merck & Co Inc. (NYSE:MRK) is one of the best stocks to invest in, according to billionaire D.E. Shaw. On October 30, Merck & Co Inc. (NYSE:MRK) posted third-quarter 2025 sales of $17.3 billion, up 4% from last year. KEYTRUDA led the way with $8.1 billion in sales, rising 10%. WINREVAIR saw a sharp jump […]",
    "url": "https://finnhub.io/api/news?id=f40e33632da0c4736605a7e4b2f107f80cb2b64d5bc2a05ca4dc9d7b895784fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762165920,
      "headline": "Merck & Co. Inc. (MRK) Reports Solid Q3 with Strong Drug Sales and Pipeline Progress",
      "id": 137302324,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co Inc. (NYSE:MRK) is one of the best stocks to invest in, according to billionaire D.E. Shaw. On October 30, Merck & Co Inc. (NYSE:MRK) posted third-quarter 2025 sales of $17.3 billion, up 4% from last year. KEYTRUDA led the way with $8.1 billion in sales, rising 10%. WINREVAIR saw a sharp jump […]",
      "url": "https://finnhub.io/api/news?id=f40e33632da0c4736605a7e4b2f107f80cb2b64d5bc2a05ca4dc9d7b895784fc"
    }
  },
  {
    "ts": null,
    "headline": "2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid",
    "summary": "Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.",
    "url": "https://finnhub.io/api/news?id=75b0098a3761282f8cb616a62525f528f06a5e796ee28fec41ba696c26973b91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762145031,
      "headline": "2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid",
      "id": 137302241,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.",
      "url": "https://finnhub.io/api/news?id=75b0098a3761282f8cb616a62525f528f06a5e796ee28fec41ba696c26973b91"
    }
  }
]